Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 62 clinical trials
Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication

without bismuth versus amoxicillin-metronidazole bismuth quadruple therapy (AM-BQT) as first-line regimens for H. pylori eradication. The aims of this study are: to compare the

bismuth
gastritis
metronidazole
rabeprazole
amoxicillin
  • 15 views
  • 23 Mar, 2022
  • 1 location
Short Therapy for Febrile UTI in Childhood

antibiotic, chosen between amoxicillin and clavulanic acid or a third-generation cephalosporin (ceftibuten), for a minimum of seven to a maximum of 14 days. In an antibiotic overuse-sparing model, proper

fever
urinary catheterization
antibiotic therapy
nitrite
urine culture
  • 7 views
  • 17 Dec, 2021
  • 1 location
A Multicentre Randomized as a Double Blind Study Triple Placebo Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmo ditis Among Adults

The primary outcome measure is to compare efficacy of an association of Secnidazol(2g)-Ciprofloxacin(1g) (during 3 days) versus 3g of Amoxicillin-Clavulanic Acid during 10 days for the

  • 16 views
  • 08 Nov, 2020
  • 1 location
Switch to Oral Antibiotics in Gram-negative Bacteremia (SOAB)

. The bloodstream isolate must be susceptible to amoxicillin, amoxicillin-clavulanate, fluoroquinolones, oral cephalosporins and/or trimethoprim-sulfamethoxazole and the subject must be able to take

  • 77 views
  • 18 Apr, 2022
  • 7 locations
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

The researchers collect treatment-naive H.pylori-positive patients from the outpatient clinic. The subjects were randomized to receive a 10-day or 14-day course of quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates, patient compliance and cost-effectiveness index of …

  • 0 views
  • 09 Jul, 2022
  • 5 locations
Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy (Hp)

Helicobacter pylori (H. pylori) is closely related to the occurrence of gastric cancer and other diseases. The discovery and eradication of H. pylori is of great significance for the prevention and treatment of related diseases. Oral H. pylori may act as a "reservoir" to cause H. pylori to spread between …

  • 0 views
  • 28 Jul, 2022
  • 1 location
ILTHPI - Comparison of Medicament Containing Tetracycline Metronidazole Bismuth Versus Amoxicillin Metronidazole Clarithromycin

treatment of H. pylori in 2017, the first line therapeutic regiment of H. pylori containing Amoxicillin, Clarithromycin, and Metronidazole if the rate of Clarithromycin resistance is below 15%, while the

  • 0 views
  • 30 Apr, 2021
  • 1 location
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

), as the first-line option in areas with significant double resistance to metronidazole and clarithromycin. Another option currently being investigated is the double therapy with amoxicillin in high

adenocarcinoma
gastric adenocarcinoma
Accepts healthy volunteers
antibiotics
endoscopy
  • 0 views
  • 07 Nov, 2021
  • 1 location
Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Primary Objective: To evaluate the clinical efficacy of pristinamycin at a dose of 2g x 2/day for 2 days then 1g x 3/day for 5 to 7 days versus amoxicillin 1g x3 /day for 7 to 9 days, 5

pneumonia
amoxicillin
procalcitonin
community acquired pneumonia
  • 0 views
  • 08 Jul, 2022
  • 14 locations
Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Primary Objective: To evaluate the clinical efficacy of pristinamycin at a dose of 2g x 2/day for 2 days then 1g x 3/day for 5 to 7 days versus amoxicillin 1g x3 /day for 7 to 9 days, 5

fever
x-rays
chest pain
shortness of breath
cough
  • 51 views
  • 22 Jul, 2022
  • 15 locations